🚨 In Case You Missed It Senti joined Virtual Investor, where Dr. Kanya Rajangam, President and Head of R&D, shared insights on the recommended Phase 2 dose of SENTI-202, our potential first-in-class CAR-NK therapy for AML and other blood cancers. Watch the full segment: https://lnkd.in/e8GvgAmb #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
Senti Biosciences
Biotechnology Research
South San Francisco, CA 11,268 followers
Outsmarting complex diseases with more intelligent medicines
About us
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address. For more information, please visit the Senti Bio website at https://www.sentibio.com.
- Website
-
http://www.sentibio.com
External link for Senti Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, CA
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Synthetic Biology, Gene Therapy, and Cell Therapy
Locations
-
Primary
Get directions
2 Corporate Drive
First Floor
South San Francisco, CA 94080, US
Employees at Senti Biosciences
-
Toby Morning
Dad, Founder @ AI Native Studio | Product Leader | CTO | Mentor | Community Builder | Open Source Advocate | Advisor | "שדכן" (Shadkhan) 👊🏾🦄 | 🌍…
-
Frances Schulz, CPA
Senior Life Sciences Executive | Public Company Board Member | Audit Committee Chairperson | Expertise in Guiding Companies to Execute Complex…
-
Melissa Woodrow
-
D. Jeffery Grimes
Updates
-
We are excited to announce that Dr. Kanya Rajangam, President, Head of Research & Development, and Chief Medical Officer, will be presenting at the MedInvest Biotech & Pharma Investor Conference taking place September 24–25 in Palo Alto, CA. #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
Senti Bio to Present at the MedInvest Biotech & Pharma Conference on Wednesday, September 24th at 9:55 AM PT https://bit.ly/47PEmrY #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
Tomorrow at 9:05 AM PT, Vice President of Research Brian Garrison will present on Next-Generation Personalized Cell Therapy Engineering Innovations at Advanced Therapies Xchange in San Francisco, CA. #SNTI #AML #CellTherapy
-
-
Halfway through Blood Cancer Awareness Month, we’re reminded that behind every statistic is a person — a patient, a caregiver, a loved one — facing the challenges of blood cancer. Let’s continue to raise awareness, share knowledge and stand together in hope. #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
If you missed our CEO, Tim Lu, at the H.C. Wainwright 27th Annual Global Investment Conference, don’t worry — you can watch the full presentation now! 🎥 Replay available here: https://bit.ly/4mK46dE #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
🚨 Starting Soon at 2:00 PM ET! Don’t miss #SNTI CEO Tim Lu live at the H.C. Wainwright 27th Annual Global Investment Conference in New York City! Can’t attend in person? Access the webcast here: https://bit.ly/4mK46dE $SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
Exciting news! #SNTI is set to present at the H.C. Wainwright 27th Annual Global Investment Conference. Don’t miss CEO Tim Lu live in New York City on September 8 at 2:00 PM ET! https://bit.ly/4mK46dE #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
September marks Blood Cancer Awareness Month — a time to stand with patients, survivors and families, and to raise awareness of the urgent need for better detection, treatment, and support. Together, we can make a difference. Learn more//bit.ly/3TfRvSU #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-
-
September marks Blood Cancer Awareness Month — a time to stand with patients, survivors and families, and to raise awareness of the urgent need for better detection, treatment, and support. Together, we can make a difference. Learn more//bit.ly/3TfRvSU #SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
-